How is AI revolutionizing oncology data? Find out in this special 'New Frontiers' episode (aired on Bloomberg) that explores the evolution of AI-powered oncology Data Intelligence with @Larvol.

#LARVOL #BloombergTV #NewFrontiers #Tech #Healthcare #Oncology #CancerResearch cologyData | @brunolarvol

Looking for your next Oncology Sales & Marketing leadership opportunity?

We've compiled a list of current US-based Oncology Sales & Marketing openings from Top pharmaceutical companies spanning multiple therapeutic areas and leadership levels.

Download the November 2026 opportundrive.google.com/file/d/1jDOGrq…

#LARVOL #CancerResearch #CancerData #Oncology #ClinicalTrials #PharmaCareers #Biopharma #LifeSciences #MarketingLeadership #JobOpportunities

🚨Breaking🚨

FDA Grants Accelerated Approval to RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) as First and Only Dual-Targeted Therapy for Advanced Head and Neck Cancer

fda.gov/news-events/pr…

Learn more 👉 clin.larvol.com/trial-detail/N…

#LARVOL #CancerResearch #CancerData ghts #ClinicalTrials #FDA #FDAApproval #HeadAndNeckCancer #HNC #RybrevantFaspro | @OncBrothers | @COlazagasti | @drdeniztural | @PaulJiL | @JiaJennyLiu

@Larvol Oncology Podcast | Episode #49 x.com/i/broadcasts/2…

🚨Breaking🚨

Pin Therapeutics’ CK1α degrader receives U.S. FDA fast track designation for adenocystic carcinoma treatment

pintherapeutics.com/eng/investment…

#LARVOL #CancerResearch #CancerData #Oncology #OncologyInsights #ClinicalTrials #FDA #FDAApproval #AdenocysticCarcinoma

🚨Breaking🚨

U.S. FDA Grants Priority Review to BeOne Medicines’ BRUKINSA Combination in First-Line Mantle Cell Lymphoma

businesswire.com/news/home/2026…

Learn more 👉 clin.larvol.com/trial-detail/N…

#LARVOL #CancerResearch #CancerData #Oncology #CancerData #Oncology #OncologyInsights DAApproval #Lymphoma #LYMSM

EORTC-NCI-AACR 2026: Abstracts Released

Explore more about oncology conferences, top trials, and reactions from oncologists: clin.larvol.com

#LARVOL #CancerResearch #CancerData #Oncology #CancerData #Oncology #OncologyInsights #ClinicalTrials #ENAsymp26 | @AACR | el | @VivekSubbiah | @SuyogCancer | @dr_yakupergun | @stolaney1

ASH 2026: Abstracts Released

Explore more about oncology conferences, top trials, and reactions from oncologists: clin.larvol.com

#LARVOL #ASH26 #CancerResearch #CancerData #Oncology #CancerData #Oncology #OncologyInsights #ClinicalTrials #ASH2026 #Hematology #Leukemia oma #BloodCancer #HemeOnc #MMSM #LEUSM #LYMSM | @ASH_hematology | @majorajay | @smbenlazar | @doctorpemm | @mtmdphd | @RahulBanerjeeMD | @VincentRK

SITC 2026: Abstracts are released!

Explore more about oncology conferences, top trials, and reactions from oncologists: clin.larvol.com

#LARVOL #SITC2026 #CancerResearch #CancerData #Oncology #OncologyInsights #ClinicalTrials #SITC26 #Immunotherapy | @sitcancer | iri | @DrJNaidoo | @CathyEngMD | @stolaney1 | @GIcancerDoc | @ErikaHamilton9 | @SuyogCancer

🚨Breaking🚨

Vivesto receives Orphan Drug Designation in the U.S. for Cantrixil in AML

vivesto.com/en/vivesto-rec…

#LARVOL #CancerResearch #CancerData #Oncology #OncologyInsights #ClinicalTrials #FDA #FDAApproval #AML #Leukemia #LEUSM

Here's our list of the Top 30 Oncology Conferences worldwide to help keep track of the major meetings shaping cancer research and clinical practice in 2026.

From global congresses to disease-specific meetings, these conferences are where many of the most important trial s happen. Explore more about oncology conferences, top trials, and reactions from oncologists: clin.larvol.com

#LARVOL #Oncology #CancerResearch #CancerData #CancerCare #OncologyUpdates #OncologyConferences #OncologyInsights #GI26 #GU26 #ASCO26 #EHA26 #AACR26 #ESMO26 #SITC26 #ASH26 #SABCS26 #2026Events #MedicalConferences

The conferences: @ASCO | @ASH_hematology | @SABCSSanAntonio | @EHA_Hematology | @myESMO | @sitcancer | @IASLC | @SocietyofHemOnc | @AACR

Here are key cancer awareness dates and months to note in 2026 across oncology.

Explore more about oncology conferences, top trials, and reactions from oncologists: clin.larvol.com

#LARVOL #Oncology #CancerCare #CancerAwarenes #BreastCancer #BCSM #LungCancer #LCSM cer #GUCSM #Melanoma #Lymphoma #Leukemia #MultipleMyeloma #HEMSM #MMSM #LEUSM #LYMSM #HeadAndNeckCancer #KindneyCancer #ColorectalCancer #BloodCancer

Happy Halloween from Team @Larvol 👻🎃

#LARVOL #CancerResearch #CancerData #Oncology #OncologyInsights #HappyHalloween #Halloween2026 #SpookySeason #TrickOrTreat #Boo #SpookyVibes

🚨Breaking🚨

Twist Bioscience Launches MRD Express with Rapid Turnaround Time

investors.twistbioscience.com/news-releases/…

#LARVOL #CancerResearch #CancerData #Oncology #OncologyInsights #ClinicalTrials #MRDExpressTest #SolidTumor

Most active cancer institutes on 𝕏 during @myESMO 2026.

Explore #ESMO26 insights here: clin.larvol.com/conference/abs…

#LARVOL #ESMO2026 #CancerResearch #CancerData #Oncology #OncologyInsights #MedicalOncology #ClinicalTrials | @RenovaHospitals | @DanaFarber | @AnkaraUni | BartsHealth | @NorthwellHealth | @SarahCannonDocs | @NarayanaHealth | @BCCancer | @Nanavati_H | @juntendo1838 | @OSUCCC_James | @hospitalclinic | @WmsCInstitute | @SylvesterCancer | @MemorialSaglik | @cityofhope | @DrRishabhOnco | @PTarantinoMD | @DrChoueiri | @Erman_Akkus | @DrYukselUrun | @dr_yakupergun | @SuyogCancer | @tompowles1 | @GIMedOnc | @DrBarbiOnc | @HHorinouchi | @ErikaHamilton9 | @DavidRSpigel | @ChandrakanthMv | @DraMartinezLago | @GillSharlene | @roxboxfix | @MamMa_mimumemo | @kazuki_nozawa | @M_Torasawa | @FordePatrick | @gerryhanna | @DrKarineTawagi | @MarioBalsaMD | @NReguart | @jasonwilliamsmd | @amerseburger | @barriere_dr | @GlopesMd | @Latinamd | @hoperugo

🔷 Toward prolonged disease control: dMMR endometrial cancer in the immunotherapy era

For years, carboplatin + paclitaxel was the standard first-line backbone for primary advanced or recurrent endometrial cancer, before molecular classification began to reshape treatment MO 2026, the label-based evidence showing how immunotherapy has reshaped the PFS benchmark in dMMR disease, through the regimens studied in RUBY, KEYNOTE-868/NRG-GY018 and DUO-E. These separate trials illustrate the shift but do not establish comparative efficacy between regimens.

🔷 KEYNOTE-C93: a potential chemotherapy-free first-line approach?

At @myESMO 2026 (LBA12), phase 3 KEYNOTE-C93 showed improved PFS with pembrolizumab alone versus carboplatin + paclitaxel in dMMR advanced or recurrent endometrial cancer (median 38.2 vs 8.4 months; HR 0.57). OS numerically favored pembrolizumab (HR 0.77), without statistical significance; 85% of chemo-arm progressors later received IO.

With checkpoint inhibitors now established in first-line dMMR disease and a chemotherapy-free option emerging, where does the next step change come from? Smarter IO combinations, earlier use in the curative setting, or something else?

Explore #ESMO26 insights here: clin.larvol.com/conference/abs…

#LARVOL #ESMO2026 #CancerResearch #CancerData #Oncology #OncologyInsights #MedicalOncology #ClinicalTrials #EndometrialCancer #GynecologicOncology #GYNSM #Immunotherapy #CompetitiveIntelligence | @ErikaHamilton9 | @ShannonWestin | @Sushilberiwal | @DrBarbiOnc | @drteplinsky | @MAvilaMD

At @myESMO 2026, the results are in, and we compared our AI forecasts with the reported control-arm survival curves.

Using LLM-based and machine learning models, we predicted key OS and PFS outcomes before the data were publicly available.

In VOLGA, KEYNOTE-B49, FINER, and ves tracked the reported results closely.

Where did AI get it right, and where did it miss? Here’s how the forecasts compare.

Learn more 👇
▶️ VOLGA: clin.larvol.com/trial-detail/N…
▶️ KEYNOTE-B49: clin.larvol.com/trial-detail/N…
▶️ FINER: clin.larvol.com/trial-detail/N…
▶️ DeLLphi-305: clin.larvol.com/trial-detail/N…

Explore #ESMO26 insights here: clin.larvol.com/conference/abs…

#LARVOL #ESMO2026 #CancerResearch #CancerData #Oncology #OncologyInsights #MedicalOncology #ClinicalTrials #LungCancer #esSCLC #LCSM #BreastCancer #BCSM #MIBC #BladderCancer #GenitourinaryCancer #GUCancer #GUCSM | @DrChoueiri | @drenriquegrande | @stolaney1 | @kazuki_nozawa | @dr_yakupergun | @ErikaHamilton9 | @StephenVLiu | @lungoncdoc

SAFFRON trial: Updated data in 2L+ EGFRm MET+ LA/m NSCLC: MET Inhibitors + Osimertinib from @myESMO 2026, adapted from Dr. Ross Soo 👉 x.com/StephenVLiu/st…

Updated landscape: clin.larvol.com/landscape/473/…

Explore #ESMO26 insights here: clin.larvol.com/conference/abs…

#LARVOL #ESMO2026 Data #Oncology #OncologyInsights #MedicalOncology #ClinicalTrials #LungCancer #NSCLC #LCSM | @DrJNaidoo | @StephenVLiu | @HHorinouchi | @ADesaiMD | @Tony_Calles

Happy Birthday, @brunolarvol! 🎉

Wishing you a fantastic year ahead, filled with new milestones, exciting opportunities, and continued success! 🎂🎈

Thank you for motivating us to think bigger, aim higher, and make a difference.

#HappyBirthday #LARVOL

Immuno-Oncology (IO): Top trending companies on 𝕏 during @myESMO 2026.

Explore #ESMO26 insights here: clin.larvol.com/conference/abs…

#LARVOL #ESMO2026 #CancerResearch #CancerData #Oncology #OncologyInsights #MedicalOncology #ClinicalTrials #ImmunoOncology #Immunotherapy | ueiri | @Erman_Akkus | @tompowles1 | @SuyogCancer | @DrYukselUrun | @GIMedOnc | @dr_yakupergun | @PTarantinoMD | @DrKarineTawagi | @HHorinouchi | @ChandrakanthMv | @jasonwilliamsmd | @DraMartinezLago | @GillSharlene

BsAb: Top trending companies on 𝕏 during @myESMO 2026.

Explore #ESMO26 insights here: clin.larvol.com/conference/abs…

#LARVOL #ESMO2026 #CancerResearch #CancerData #Oncology #OncologyInsights #MedicalOncology #ClinicalTrials #BsAbs #BispecificAntibodies | @DrRishabhOnco | ncer | @barriere_dr | @M_Torasawa | @HHorinouchi | @GIMedOnc | @DraMartinezLago | @tompowles1 | @FordePatrick | @GillSharlene | @ChandrakanthMv | @dr_yakupergun | @ErulEnes | @DrYukselUrun